Samil Pharm (000520) - Total Liabilities

Latest as of June 2025: ₩226.31 Billion KRW ≈ $153.37 Million USD

Based on the latest financial reports, Samil Pharm (000520) has total liabilities worth ₩226.31 Billion KRW (≈ $153.37 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 000520 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Samil Pharm - Total Liabilities Trend (2011–2024)

This chart illustrates how Samil Pharm's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 000520 current and non-current assets.

Samil Pharm Competitors by Total Liabilities

The table below lists competitors of Samil Pharm ranked by their total liabilities.

Company	Country	Total Liabilities
Abra Information Technologies TA:ABRA	Israel	ILA283.61 Million
We&Win Diversification Co Ltd TWO:4113	Taiwan	NT$12.42 Billion
Procaps Group SA NASDAQ:PROC	USA	$460.10 Million
Corner Growth Acquisition Corp NASDAQ:COOL	USA	$12.68 Million
Boldt S.A BA:BOLT	Argentina	AR$60.83 Billion
Black Diamond Therapeutics Inc NASDAQ:BDTX	USA	$28.94 Million
Sunspring Metal Corp TW:2062	Taiwan	NT$3.30 Billion
Hiap Teck Venture Bhd KLSE:5072	Malaysia	RM605.18 Million

Liability Composition Analysis (2011–2024)

This chart breaks down Samil Pharm's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Samil Pharm balance sheet independence to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.63	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.52	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.60	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Samil Pharm's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Samil Pharm (2011–2024)

The table below shows the annual total liabilities of Samil Pharm from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩218.95 Billion ≈ $148.38 Million	-9.84%
2023-12-31	₩242.85 Billion ≈ $164.58 Million	+5.19%
2022-12-31	₩230.88 Billion ≈ $156.46 Million	+43.71%
2021-12-31	₩160.66 Billion ≈ $108.88 Million	+25.41%
2020-12-31	₩128.11 Billion ≈ $86.82 Million	+5.35%
2019-12-31	₩121.60 Billion ≈ $82.41 Million	+32.37%
2018-12-31	₩91.87 Billion ≈ $62.26 Million	+8.96%
2017-12-31	₩84.31 Billion ≈ $57.14 Million	+75.19%
2016-12-31	₩48.12 Billion ≈ $32.61 Million	+7.18%
2015-12-31	₩44.90 Billion ≈ $30.43 Million	-15.08%
2014-12-31	₩52.88 Billion ≈ $35.83 Million	+15.75%
2013-12-31	₩45.68 Billion ≈ $30.96 Million	-5.07%
2012-12-31	₩48.12 Billion ≈ $32.61 Million	-11.86%
2011-12-31	₩54.60 Billion ≈ $37.00 Million	--

About Samil Pharm

KO:000520 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$113.80 Million

₩167.93 Billion KRW

Market Cap Rank

#18812 Global

#881 in Korea

Share Price

₩7910.00

Change (1 day)

-3.77%

52-Week Range

₩5830.00 - ₩12310.00

All Time High

₩23603.13